<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - 02/28/2025</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Progress note - 02/28/2025</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">Michael A SOSSAMAN</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">June 21, 1957 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Male</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>White</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Not Hispanic or Latino</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Postal Address:<br/>5227 EAST RD<br/>BAYTOWN, TX 77521-9057, US<br/><br/>Primary Home Phone:  281-684-5815<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">572600 2.16.840.1.113883.4.391.327187<br/>572600 2.16.840.1.113883.4.391.327187.1<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">d045f8d7-3638-448f-aef8-99441b40bf3f 2.16.840.1.113883.4.391</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">April 3, 2025, 09:52:21 -0400 </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Lorenzo Bortolotti</td></tr><tr><td class="td_header_role_value internal_format">1600 JAMES BOWIE DR<br/>STE D115<br/>BAYTOWN, TX 77520-3385, US<br/><br/>Tel:  281-425-3800<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">eClinicalWorks</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">23014856 2.16.840.1.113883.4.391.327187</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">ambulatory</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From February 28, 2025, 09:30:00   to February 28, 2025, 09:50:00  </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value">id:  2.16.840.1.113883.4.391.327187</td></tr><tr><td class="td_header_role_name"><span class="td_label">Responsible party</span></td><td class="td_header_role_value">Lorenzo Bortolotti</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">1600 JAMES BOWIE DR<br/>STE D115<br/>BAYTOWN, TX 77520-3385, US<br/><br/>Tel:  281-425-3800<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Guarantor</span></td><td class="td_header_role_value">Michael SOSSAMAN<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Tel:  281-684-5815<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Legal authenticator</span></td><td class="td_header_role_value">Lorenzo Bortolotti signed at February 28, 2025 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">1600 JAMES BOWIE DR<br/>STE D115<br/>BAYTOWN, TX 77520-3385, US<br/><br/>Tel:  281-425-3800<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">MyCare Medical Group</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">1785 NORTHPOINTE PKWY<br/>STE 300<br/>LUTZ, FL 33558-5742, US<br/><br/>Tel:  813-536-7277<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">REASON FOR VISIT</a></li><li><a href="#id3">Medications</a></li><li><a href="#id4">Problems</a></li><li><a href="#id5">Vital Signs</a></li><li><a href="#id6">Encounters</a></li><li><a href="#id7">Assessments</a></li><li><a href="#id8">Plan Of Treatment</a></li><li><a href="#id9">Progress Notes</a></li><li><a href="#id10">History and Physical Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">REASON FOR VISIT</a></h3><div>follow-up, lab results</div><h3><a name="id3" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Ferrous Sulfate 325 (65 Fe) MG</td><td ID="instruction1">1 tablet Orally Once a week for 60 days for 60 days</td><td/><td>02/28/2025</td><td/><td>Active</td></tr><tr><td ID="medication2">Magnesium Oxide 400 MG</td><td ID="instruction2">1 tablet Orally Once a day for 7 days for 7 days</td><td/><td>02/28/2025</td><td/><td>Active</td></tr><tr><td ID="medication3">amLODIPine Besylate 10 MG</td><td ID="instruction3">1 tablet Once a day for 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">Ezetimibe 10 MG</td><td ID="instruction4">1 tablet Once a day for 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">Atorvastatin Calcium 40 MG</td><td ID="instruction5">1 tablet Once a day for 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">Montelukast Sodium 10 MG</td><td ID="instruction6">1 tablet Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">HYDROcodone-Acetaminophen</td><td ID="instruction7"/><td/><td/><td/><td>Active</td></tr><tr><td ID="medication8">Xarelto 20 MG</td><td ID="instruction8">1 tablet Once a day for 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication9">metFORMIN HCl 500 MG</td><td ID="instruction9">1 tablet Once a day for 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication10">Pregabalin</td><td ID="instruction10"/><td/><td/><td/><td>Active</td></tr><tr><td ID="medication11">hydroCHLOROthiazide 12.5 MG</td><td ID="instruction11">1 tablet Once a day for 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication12">Flecainide Acetate 50 MG</td><td ID="instruction12">1 tablet TWICE A DAY</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication13">Lisinopril 20 MG</td><td ID="instruction13">1 tablet Once a day for 30 days</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>Abnormal feces (271840007)</td><td ID="Problem1">Positive colorectal cancer screening using Cologuard test (R19.5)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems1notes">has colonoscopy scheduled.</td></tr><tr><td>Problem</td><td/><td ID="Problem2">Type 2 diabetes mellitus with other specified complication (E11.69)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems2notes">stable a1c at 6.9 / continue metformin.</td></tr><tr><td>Problem</td><td>Diabetic renal disease (127013003)</td><td ID="Problem3">Type 2 diabetes mellitus with diabetic chronic kidney disease (E11.22)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems3notes">stable / advised to hydrate, avoid nsaids and monitor gfr.</td></tr><tr><td>Problem</td><td>Peripheral circulatory disorder associated with diabetes mellitus (421895002)</td><td ID="Problem4">Type 2 diabetes mellitus with other circulatory complications (E11.59)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id5" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Height</th><td>69 in</td><td>02/28/2025</td></tr><tr><th ID="vital2">Weight</th><td>206.8 lbs</td><td>02/28/2025</td></tr><tr><th ID="vital3">Weight-kg</th><td>93.8 kg</td><td>02/28/2025</td></tr><tr><th ID="vital4">BMI</th><td>30.54 kg/m2</td><td>02/28/2025</td></tr><tr><th ID="vital5">Blood pressure systolic</th><td>107 mm Hg</td><td>02/28/2025</td></tr><tr><th ID="vital6">Blood pressure diastolic</th><td>64 mm Hg</td><td>02/28/2025</td></tr><tr><th ID="vital7">Heart Rate</th><td>74 /min</td><td>02/28/2025</td></tr><tr><th ID="vital8">Temperature</th><td>98.2 degrees Fahrenheit</td><td>02/28/2025</td></tr><tr><th ID="vital9">Respiratory Rate</th><td>16 /min</td><td>02/28/2025</td></tr><tr><th ID="vital10">Oximetry</th><td>96 %</td><td>02/28/2025</td></tr></tbody></table></div><h3><a name="id6" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM Baytown James Bowie PCP</td><td>1600 JAMES BOWIE DR STE D115 BAYTOWN, TX 77520-3385</td><td>02/28/2025</td><td>Lorenzo Bortolotti</td><td>Hypertensive heart and CKD I13.10 ; CKD- Stage 2 N18.2 ; CAD in native artery I25.10 ; Atrial fibrillation, persistent I48.19 ; Prediabetes R73.03 ; COPD (chronic obstructive pulmonary disease) J44.9 ; Tobacco abuse Z72.0 ; Hyperlipidemia E78.5 ; Glaucoma (increased eye pressure) H40.9 ; SCREENING FOR PROSTATE CANCER Z12.5 ; Positive colorectal cancer screening using Cologuard test R19.5 ; Type 2 diabetes mellitus with other specified complication E11.69 ; Type 2 diabetes mellitus with diabetic chronic kidney disease E11.22 and Type 2 diabetes mellitus with other circulatory complications E11.59</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th><th>Section Notes</th></tr></thead><tbody><tr><td ID="ref1">02/28/2025</td><td>Hypertensive heart and CKD (ICD-10 - I13.10)</td><td>stable / continue amlodipine, hctz, lisinopril.</td><td/><td/><td/></tr><tr><td ID="ref2">02/28/2025</td><td>CKD- Stage 2 (ICD-10 - N18.2)</td><td>stable / advised to hydrate, avoid nsaids and monitor gfr.</td><td/><td/><td/></tr><tr><td ID="ref3">02/28/2025</td><td>CAD in native artery (ICD-10 - I25.10)</td><td>stable / continue ezetimibe &amp; xarelto.</td><td/><td/><td/></tr><tr><td ID="ref4">02/28/2025</td><td>Atrial fibrillation, persistent (ICD-10 - I48.19)</td><td>stable / continue meds as per Cardiologist.</td><td/><td/><td/></tr><tr><td ID="ref5">02/28/2025</td><td>Prediabetes (ICD-10 - R73.03)</td><td/><td/><td/><td/></tr><tr><td ID="ref6">02/28/2025</td><td>COPD (chronic obstructive pulmonary disease) (ICD-10 - J44.9)</td><td>stable /monitor</td><td/><td/><td/></tr><tr><td ID="ref7">02/28/2025</td><td>Tobacco abuse (ICD-10 - Z72.0)</td><td/><td/><td/><td/></tr><tr><td ID="ref8">02/28/2025</td><td>Hyperlipidemia (ICD-10 - E78.5)</td><td>stable ldl / continue ezetimibe.</td><td/><td/><td/></tr><tr><td ID="ref9">02/28/2025</td><td>Glaucoma (increased eye pressure) (ICD-10 - H40.9)</td><td>stable / managed by ophthalmologist.</td><td/><td/><td/></tr><tr><td ID="ref10">02/28/2025</td><td>SCREENING FOR PROSTATE CANCER (ICD-10 - Z12.5)</td><td>normla psa in 2025 / repeat yearly.</td><td/><td/><td/></tr><tr><td ID="ref11">02/28/2025</td><td>Positive colorectal cancer screening using Cologuard test (ICD-10 - R19.5)</td><td>has colonoscopy scheduled.</td><td/><td/><td/></tr><tr><td ID="ref12">02/28/2025</td><td>Type 2 diabetes mellitus with other specified complication (ICD-10 - E11.69)</td><td>stable a1c at 6.9 / continue metformin.</td><td/><td/><td/></tr><tr><td ID="ref13">02/28/2025</td><td>Type 2 diabetes mellitus with diabetic chronic kidney disease (ICD-10 - E11.22)</td><td>stable / advised to hydrate, avoid nsaids and monitor gfr.</td><td/><td/><td/></tr><tr><td ID="ref14">02/28/2025</td><td>Type 2 diabetes mellitus with other circulatory complications (ICD-10 - E11.59)</td><td/><td/><td/><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">Ferrous Sulfate 325 (65 Fe) MG</td><td>1 tablet Orally Once a week for 60 days for 60 days</td><td>02/28/2025</td><td/><td/></tr><tr><td ID="potMeds2">Magnesium Oxide 400 MG</td><td>1 tablet Orally Once a day for 7 days for 7 days</td><td>02/28/2025</td><td/><td/></tr></tbody></table><span class="content_span">Future Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="futureTest1">2708 HEMOGLOBIN A1c</td><td>07/07/2025</td></tr><tr><td ID="futureTest2">4895 ALBUMIN/CREATININE RATIO, RANDOM URINE</td><td>07/07/2025</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: july, Reason: </td></tr><tr><td ID="futureAppt1">Provider Name:Lorenzo Bortolotti, 07/25/2025 09:00:00 AM, 1600 JAMES BOWIE DR, STE D115, BAYTOWN, TX, 77520-3385, 281-425-3800</td></tr></tbody></table></div><h3><a name="id9" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>SOSSAMAN, Michael A <span class="bold">DOB:</span> 06/21/1957 (67 yo M) <span class="bold">Acc No.</span> 572600 <span class="bold">DOS:</span> 02/28/2025</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold"/></td></tr><tr><td align="left"><span class="bold">Patient: </span>SOSSAMAN, Michael A<br/><span class="bold">Account Number: </span>572600</td><td align="right"><span class="bold">Provider: </span>Lorenzo Bortolotti, MD</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>06/21/1957<span class="bold">   Age: </span>67 Y<span class="bold">   Sex: </span>Male</td><td align="right"><span class="bold">Date: </span>02/28/2025</td></tr><tr><td><span class="bold">Phone: </span>281-684-5815</td></tr><tr><td colspan="2"><span class="bold">Address: </span>5227 EAST RD, BAYTOWN, TX-77521-9057</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   Follow-up, lab results</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">Patient is here for :</span>: <br/>       follow-up, lab results.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">General ROS</span>: <br/>      General / Constitutional: <br/>GEN: Denies: night sweats.<br/>HEAD: Denies: injury, worsening headache<br/>EYES: Denies: loss of vision, double vision<br/>LUNGS: Denies: painful breathing, hemoptysis<br/>HEART: Denies: chest pain with walking<br/>GI: Denies: hematemesis, rectal bleeding, melena<br/>NEURO: Denies: seizures, new unilateral weakness.   <br/>   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> ( 14 ) TOTAL - back surgeries 1991-2010</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> fever 02/22/23</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Family History:</span> Father: deceased. Mother: deceased. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   <span class="content_span">Tobacco-[+]</span>.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> TakingamLODIPine Besylate 10 MG Tablet 1 tablet  Once a day Atorvastatin Calcium 40 MG Tablet 1 tablet  Once a day Ezetimibe 10 MG Tablet 1 tablet  Once a day Flecainide Acetate 50 MG Tablet 1 tablet  TWICE A DAY hydroCHLOROthiazide 12.5 MG Tablet 1 tablet  Once a day Lisinopril 20 MG Tablet 1 tablet  Once a day metFORMIN HCl 500 MG Tablet 1 tablet  Once a day Montelukast Sodium 10 MG Tablet 1 tablet Orally Once a day Xarelto 20 MG Tablet 1 tablet  Once a day HYDROcodone-Acetaminophen      Pregabalin      Medication List reviewed and reconciled with the patientTaking amLODIPine Besylate 10 MG Tablet 1 tablet  Once a day Taking Atorvastatin Calcium 40 MG Tablet 1 tablet  Once a day Taking Ezetimibe 10 MG Tablet 1 tablet  Once a day Taking Flecainide Acetate 50 MG Tablet 1 tablet  TWICE A DAY Taking hydroCHLOROthiazide 12.5 MG Tablet 1 tablet  Once a day Taking Lisinopril 20 MG Tablet 1 tablet  Once a day Taking metFORMIN HCl 500 MG Tablet 1 tablet  Once a day Taking Montelukast Sodium 10 MG Tablet 1 tablet Orally Once a day Taking Xarelto 20 MG Tablet 1 tablet  Once a day Taking HYDROcodone-Acetaminophen      Taking Pregabalin      Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> N.K.D.A.no[Allergies Verified]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> Ht: 69 in, Wt: <span class="bold">206.8</span> lbs, Wt-kg: 93.8 kg, BMI: <span class="bold">30.54</span> Index, BP: <span class="bold">107/64</span> mm Hg, HR: <span class="bold">74</span> /min, Temp: <span class="bold">98.2</span> F, RR: <span class="bold">16</span> /min, Oxygen sat %: <span class="bold">96</span> %, Body Surface Area: 2.13.<br/></td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td><span class="bold">   Past Orders:</span></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:1000 CBC W/AUTO DIFF (Order Date - 01/30/2025) (Collection Date &amp; Time - 01/30/2025 04:14 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        WBC</td><td align="left">9.1</td><td align="left"/><td align="left">3.5-11.0 - K/UL</td></tr><tr><td align="left">        RBC</td><td align="left">4.06</td><td align="left">L</td><td align="left">4.50-6.10 - M/UL</td></tr><tr><td align="left">        HEMOGLOBIN</td><td align="left">12.5</td><td align="left">L</td><td align="left">13.5-17.0 - G/DL</td></tr><tr><td align="left">        HEMATOCRIT</td><td align="left">39.2</td><td align="left">L</td><td align="left">40.0-51.0 - %</td></tr><tr><td align="left">        MCV</td><td align="left">96.6</td><td align="left"/><td align="left">80.0-99.0 - fL</td></tr><tr><td align="left">        MCH</td><td align="left">30.8</td><td align="left"/><td align="left">25.0-33.0 - PG</td></tr><tr><td align="left">        MCHC</td><td align="left">31.9</td><td align="left"/><td align="left">31.0-36.0 - G/DL</td></tr><tr><td align="left">        RDW</td><td align="left">12.3</td><td align="left"/><td align="left">11.5-15.0 - %</td></tr><tr><td align="left">        NEUTROPHILS</td><td align="left">69.6</td><td align="left"/><td align="left"> - %</td></tr><tr><td align="left">        LYMPHOCYTES</td><td align="left">22.4</td><td align="left"/><td align="left"> - %</td></tr><tr><td align="left">        MONOCYTES</td><td align="left">7.1</td><td align="left"/><td align="left"> - %</td></tr><tr><td align="left">        EOSINOPHILS</td><td align="left">0.5</td><td align="left"/><td align="left"> - %</td></tr><tr><td align="left">        BASOPHILS</td><td align="left">0.1</td><td align="left"/><td align="left"> - %</td></tr><tr><td align="left">        IMMATURE GRANULOCYTES</td><td align="left">0.3</td><td align="left"/><td align="left"> - %</td></tr><tr><td align="left">        NUCLEATED RBC'S</td><td align="left">0.0</td><td align="left"/><td align="left">0.0 -  /100 WBC'S</td></tr><tr><td align="left">        PLATELET COUNT</td><td align="left">313</td><td align="left"/><td align="left">130-400 - K/UL</td></tr><tr><td align="left">        ABSOLUTE NEUTROPHILS</td><td align="left">6.32</td><td align="left"/><td align="left">1.50-7.50 - K/UL</td></tr><tr><td align="left">        ABSOLUTE LYMPHOCYTES</td><td align="left">2.04</td><td align="left"/><td align="left">1.00-4.00 - K/UL</td></tr><tr><td align="left">        ABSOLUTE MONOCYTES</td><td align="left">0.65</td><td align="left"/><td align="left">0.20-1.00 - K/UL</td></tr><tr><td align="left">        ABSOLUTE EOSINOPHILS</td><td align="left">0.05</td><td align="left"/><td align="left">0.00-0.50 - K/UL</td></tr><tr><td align="left">        ABSOLUTE BASOPHILS</td><td align="left">0.01</td><td align="left"/><td align="left">0.00-0.20 - K/UL</td></tr><tr><td align="left">        ABS IMMATURE GRANULOCYTES</td><td align="left">0.03</td><td align="left"/><td align="left">0.00-0.10 - K/UL</td></tr><tr><td align="left">        ABS NUCLEATED RBCS</td><td align="left">0.00</td><td align="left"/><td align="left">0.00-0.11 - K/UL</td></tr><tr><td colspan="4"><span class="content_span">        Notes: see tel enc</span></td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:9179 COMPREHENSIVE METABOLIC PANEL (Order Date - 01/30/2025) (Collection Date &amp; Time - 01/30/2025 04:14 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        BUN</td><td align="left">10</td><td align="left"/><td align="left">8-23 - MG/DL</td></tr><tr><td align="left">        CREATININE</td><td align="left">1.07</td><td align="left"/><td align="left">0.80-1.40 - MG/DL</td></tr><tr><td align="left">         eGFR NON-AFRICAN AMER.</td><td align="left">76</td><td align="left"/><td align="left">&gt;60 - ML/MIN/1.73</td></tr><tr><td align="left">        SODIUM</td><td align="left">141</td><td align="left"/><td align="left">133-146 - MEQ/L</td></tr><tr><td align="left">        POTASSIUM</td><td align="left">4.5</td><td align="left"/><td align="left">3.5-5.4 - MEQ/L</td></tr><tr><td align="left">        CHLORIDE</td><td align="left">102</td><td align="left"/><td align="left">95-107 - MEQ/L</td></tr><tr><td align="left">        CARBON DIOXIDE</td><td align="left">27</td><td align="left"/><td align="left">19-31 - MEQ/L</td></tr><tr><td align="left">        CALCIUM</td><td align="left">9.9</td><td align="left"/><td align="left">8.5-10.5 - MG/DL</td></tr><tr><td align="left">        PROTEIN, TOTAL</td><td align="left">7.3</td><td align="left"/><td align="left">6.1-8.3 - G/DL</td></tr><tr><td align="left">        ALBUMIN</td><td align="left">4.6</td><td align="left"/><td align="left">3.5-5.2 - G/DL</td></tr><tr><td align="left">        BILIRUBIN, TOTAL</td><td align="left">0.3</td><td align="left"/><td align="left">&lt;=1.2 - MG/DL</td></tr><tr><td align="left">        ALKALINE PHOSPHATASE</td><td align="left">88</td><td align="left"/><td align="left">40-125 - U/L</td></tr><tr><td align="left">        SGOT (AST)</td><td align="left">22</td><td align="left"/><td align="left">9-50 - U/L</td></tr><tr><td align="left">        SGPT (ALT)</td><td align="left">21</td><td align="left"/><td align="left">5-50 - U/L</td></tr><tr><td align="left">        GLUCOSE</td><td align="left">122</td><td align="left">H</td><td align="left">70-99 - MG/DL</td></tr><tr><td align="left">        CALCULATED BUN/CREAT</td><td align="left">9</td><td align="left"/><td align="left">6-28 - RATIO</td></tr><tr><td align="left">        CALCULATED GLOBULIN</td><td align="left">2.7</td><td align="left"/><td align="left">1.9-3.7 - G/DL</td></tr><tr><td align="left">        CALCULATED A/G RATIO</td><td align="left">1.7</td><td align="left"/><td align="left">1.0-2.6 - RATIO</td></tr><tr><td colspan="4"><span class="content_span">        Notes: see tel enc</span></td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:2836 TSH + FREE T4 PROFILE (Order Date - 01/30/2025) (Collection Date &amp; Time - 01/30/2025 04:14 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        TSH</td><td align="left">1.690</td><td align="left"/><td align="left">0.400-4.100 - UIU/ML</td></tr><tr><td align="left">        FREE T4 (THYROXINE)</td><td align="left">0.93</td><td align="left"/><td align="left">0.80-1.90 - NG/DL</td></tr><tr><td colspan="4"><span class="content_span">        Notes: see tel enc</span></td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:2708 HEMOGLOBIN A1c (Order Date - 01/30/2025) (Collection Date &amp; Time - 01/30/2025 04:14 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        HEMOGLOBIN A1c</td><td align="left">6.8</td><td align="left">H</td><td align="left">4.2-5.6 - %</td></tr><tr><td colspan="4"><span class="content_span">        Notes: see tel enc</span></td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:4228 LDL DIRECT (Order Date - 01/30/2025) (Collection Date &amp; Time - 01/30/2025 04:14 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        LDL DIRECT</td><td align="left">67</td><td align="left"/><td align="left">&lt;100 - MG/DL</td></tr><tr><td colspan="4"><span class="content_span">        Notes: see tel enc</span></td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:2606 PSA, TOTAL (Order Date - 01/30/2025) (Collection Date &amp; Time - 01/30/2025 04:14 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        PSA, TOTAL</td><td align="left">0.41</td><td align="left"/><td align="left">&lt;=4.00 - NG/ML</td></tr><tr><td colspan="4"><span class="content_span">        Notes: see tel enc</span></td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:1505 URINALYSIS WITH MICROSCOPIC (Order Date - 01/30/2025) (Collection Date &amp; Time - 01/30/2025 04:14 PM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        UROBILINOGEN</td><td align="left">0.2</td><td align="left"/><td align="left">&lt;=2.0 -  MG/DL</td></tr><tr><td align="left">        OCCULT BLOOD</td><td align="left">NEGATIVE</td><td align="left"/><td align="left">NEGATIVE - </td></tr><tr><td align="left">        EPITHELIAL CELLS</td><td align="left">0-5</td><td align="left"/><td align="left">0-5 -  /HPF</td></tr><tr><td align="left">        PROTEIN</td><td align="left">NEGATIVE</td><td align="left"/><td align="left">NEGATIVE - </td></tr><tr><td align="left">        WHITE BLOOD CELLS</td><td align="left">0-5</td><td align="left"/><td align="left">0-5 -  /HPF</td></tr><tr><td align="left">        CASTS, HYALINE</td><td align="left">NONE SEEN</td><td align="left"/><td align="left">NONE-TRACE - </td></tr><tr><td align="left">        BACTERIA</td><td align="left">NONE SEEN</td><td align="left"/><td align="left">NONE SEEN - </td></tr><tr><td align="left">        RED BLOOD CELLS</td><td align="left">0-2</td><td align="left"/><td align="left">0-2 -  /HPF</td></tr><tr><td align="left">        APPEARANCE</td><td align="left">CLEAR</td><td align="left"/><td align="left">CLEAR - </td></tr><tr><td align="left">        BILIRUBIN</td><td align="left">NEGATIVE</td><td align="left"/><td align="left">NEGATIVE - </td></tr><tr><td align="left">        COLOR</td><td align="left">YELLOW</td><td align="left"/><td align="left">YELLOW-STRAW - </td></tr><tr><td align="left">        GLUCOSE</td><td align="left">NEGATIVE</td><td align="left"/><td align="left">NEGATIVE - </td></tr><tr><td align="left">        KETONES</td><td align="left">NEGATIVE</td><td align="left"/><td align="left">NEGATIVE - </td></tr><tr><td align="left">        LEUKOCYTE ESTERASE</td><td align="left">NEGATIVE</td><td align="left"/><td align="left">NEGATIVE - </td></tr><tr><td align="left">        NITRITE</td><td align="left">NEGATIVE</td><td align="left"/><td align="left">NEGATIVE - </td></tr><tr><td align="left">        pH</td><td align="left">6.0</td><td align="left"/><td align="left">5.0-9.0 - </td></tr><tr><td align="left">        SPECIFIC GRAVITY</td><td align="left">1.012</td><td align="left"/><td align="left">1.005-1.035 - </td></tr><tr><td colspan="4"><span class="content_span">        Notes: see tel enc</span></td></tr><tr><td colspan="4"><br/></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">General Examination:</span><br/>      General appearance: alert, oriented. <br/>      HEENT pupils equally reactive, no jaundice. <br/>      Neck / thyroid: normal thyroid, no jvd. <br/>      Heart: regular rate &amp; rhythm, no murmurs. <br/>      Chest: normal expansion. <br/>      Lungs: + diminished breath sounds . <br/>      Abdomen: soft, nondistended, nontender. <br/>      Extremities no cyanosis, no edema, good distal pulses. <br/>      Musculoskeletal: + antalgic gait. <br/>      Extremities: + sen ecch.    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Hypertensive heart and CKD - I13.10 (Primary)   <content><span class="bold">Notes : </span>stable / continue amlodipine, hctz, lisinopril.</content>   2. CKD- Stage 2 - N18.2   <content><span class="bold">Notes : </span>stable / advised to hydrate, avoid nsaids and monitor gfr.</content>   3. CAD in native artery - I25.10   <content><span class="bold">Notes : </span>stable / continue ezetimibe &amp; xarelto.</content>   4. Atrial fibrillation, persistent - I48.19   <content><span class="bold">Notes : </span>stable / continue meds as per Cardiologist.</content>   5. Prediabetes - R73.03   6. COPD (chronic obstructive pulmonary disease) - J44.9   <content><span class="bold">Notes : </span>stable /monitor</content>   7. Tobacco abuse - Z72.0   8. Hyperlipidemia - E78.5   <content><span class="bold">Notes : </span>stable ldl / continue ezetimibe.</content>   9. Glaucoma (increased eye pressure) - H40.9   <content><span class="bold">Notes : </span>stable / managed by ophthalmologist.</content>   10. SCREENING FOR PROSTATE CANCER - Z12.5   <content><span class="bold">Notes : </span>normla psa in 2025 / repeat yearly.</content>   11. Positive colorectal cancer screening using Cologuard test - R19.5   <content><span class="bold">Notes : </span>has colonoscopy scheduled.</content>   12. Type 2 diabetes mellitus with other specified complication - E11.69   <content><span class="bold">Notes : </span>stable a1c at 6.9 / continue metformin.</content>   13. Type 2 diabetes mellitus with diabetic chronic kidney disease - E11.22   <content><span class="bold">Notes : </span>stable / advised to hydrate, avoid nsaids and monitor gfr.</content>   14. Type 2 diabetes mellitus with other circulatory complications - E11.59   </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Hypertensive heart and CKD</span> <br/>     <span class="Underline">LAB: 2708 HEMOGLOBIN A1c (Ordered for 07/07/2025)</span><br/>     <span class="Underline">LAB: 4895 ALBUMIN/CREATININE RATIO, RANDOM URINE (Ordered for 07/07/2025)</span></td></tr><tr><td/></tr><tr><td><span class="bold">2. CKD- Stage 2</span> <br/>     <span class="Underline">LAB: 2708 HEMOGLOBIN A1c (Ordered for 07/07/2025)</span><br/>     <span class="Underline">LAB: 4895 ALBUMIN/CREATININE RATIO, RANDOM URINE (Ordered for 07/07/2025)</span></td></tr><tr><td/></tr><tr><td><span class="bold">3. CAD in native artery</span> <br/>     <span class="Underline">LAB: 2708 HEMOGLOBIN A1c (Ordered for 07/07/2025)</span><br/>     <span class="Underline">LAB: 4895 ALBUMIN/CREATININE RATIO, RANDOM URINE (Ordered for 07/07/2025)</span></td></tr><tr><td/></tr><tr><td><span class="bold">4. Atrial fibrillation, persistent</span> <br/>     <span class="Underline">LAB: 2708 HEMOGLOBIN A1c (Ordered for 07/07/2025)</span><br/>     <span class="Underline">LAB: 4895 ALBUMIN/CREATININE RATIO, RANDOM URINE (Ordered for 07/07/2025)</span></td></tr><tr><td/></tr><tr><td><span class="bold">5. Prediabetes</span> <br/>     <span class="Underline">LAB: 2708 HEMOGLOBIN A1c (Ordered for 07/07/2025)</span><br/>     <span class="Underline">LAB: 4895 ALBUMIN/CREATININE RATIO, RANDOM URINE (Ordered for 07/07/2025)</span></td></tr><tr><td/></tr><tr><td><span class="bold">6. COPD (chronic obstructive pulmonary disease)</span> <br/>     <span class="Underline">LAB: 2708 HEMOGLOBIN A1c (Ordered for 07/07/2025)</span><br/>     <span class="Underline">LAB: 4895 ALBUMIN/CREATININE RATIO, RANDOM URINE (Ordered for 07/07/2025)</span></td></tr><tr><td/></tr><tr><td><span class="bold">7. Tobacco abuse</span> <br/>     <span class="Underline">LAB: 2708 HEMOGLOBIN A1c (Ordered for 07/07/2025)</span><br/>     <span class="Underline">LAB: 4895 ALBUMIN/CREATININE RATIO, RANDOM URINE (Ordered for 07/07/2025)</span></td></tr><tr><td/></tr><tr><td><span class="bold">8. Hyperlipidemia</span> <br/>     <span class="Underline">LAB: 2708 HEMOGLOBIN A1c (Ordered for 07/07/2025)</span><br/>     <span class="Underline">LAB: 4895 ALBUMIN/CREATININE RATIO, RANDOM URINE (Ordered for 07/07/2025)</span></td></tr><tr><td/></tr><tr><td><span class="bold">9. Glaucoma (increased eye pressure)</span> <br/>     <span class="Underline">LAB: 2708 HEMOGLOBIN A1c (Ordered for 07/07/2025)</span><br/>     <span class="Underline">LAB: 4895 ALBUMIN/CREATININE RATIO, RANDOM URINE (Ordered for 07/07/2025)</span></td></tr><tr><td/></tr><tr><td><span class="bold">10. SCREENING FOR PROSTATE CANCER</span> <br/>     <span class="Underline">LAB: 2708 HEMOGLOBIN A1c (Ordered for 07/07/2025)</span><br/>     <span class="Underline">LAB: 4895 ALBUMIN/CREATININE RATIO, RANDOM URINE (Ordered for 07/07/2025)</span></td></tr><tr><td/></tr><tr><td><span class="bold">11. Positive colorectal cancer screening using Cologuard test</span> <br/>     <span class="Underline">LAB: 2708 HEMOGLOBIN A1c (Ordered for 07/07/2025)</span><br/>     <span class="Underline">LAB: 4895 ALBUMIN/CREATININE RATIO, RANDOM URINE (Ordered for 07/07/2025)</span></td></tr><tr><td/></tr><tr><td><span class="bold">12. Others </span> <br/>Start Ferrous Sulfate Tablet Delayed Release, 325 (65 Fe) MG, 1 tablet, Orally, Once a week for 60 days, 60 days, 8, Refills 0; Start Magnesium Oxide Tablet, 400 MG, 1 tablet, Orally, Once a day for 7 days, 7 days, 7, Refills 0.  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> 3078F DIAST BP &lt; 80 MM HGG8417 BMI &gt;=30 CALCUATE W/FOLLOWUP3008F BODY MASS INDEX DOCD1159F MED LIST DOCD IN RCRD1160F RVW MEDS BY RX/DR IN RCRD3074F SYST BP LT 130 MM HG</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> july</td></tr></tbody></table></li></ul><ul><li/></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> <br/>99214 Office Visit, Est Pt., Level 4.  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> <br/>3078F DIAST BP &lt; 80 MM HG. <br/>G8417 BMI &gt;=30 CALCUATE W/FOLLOWUP. <br/>3008F BODY MASS INDEX DOCD. <br/>1159F MED LIST DOCD IN RCRD. <br/>1160F RVW MEDS BY RX/DR IN RCRD. <br/>3074F SYST BP LT 130 MM HG. </td></tr></tbody></table></li></ul><br/><tr><td valign="top"><span class="bold">Care Plan Details</span><ul><li><table cellpadding="1" cellspacing="0" border="1"><tbody/></table></li></ul></td></tr><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by Lorenzo Bortolotti , MD, K7665  on 02/28/2025 at 09:34 AM CST</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> Lorenzo Bortolotti, MD</td><td align="right"><span class="bold">Date: </span>02/28/2025</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: 04/03/2025 08:52 AM CDT</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id10" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>HPI (History of Present Illness)</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th><th>Category Notes</th></tr></thead><tbody><tr><td>Patient is here for :</td><td/><td colspan="2"/><td>follow-up, lab results</td></tr></tbody></table><br/><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th><th>Category Notes</th></tr></thead><tbody><tr><td rowspan="10">General Examination</td><td>General appearance:</td><td colspan="2">alert, oriented</td><td rowspan="10"/></tr><tr><td>Neck / thyroid:</td><td colspan="2">normal thyroid, no jvd</td></tr><tr><td>Heart:</td><td colspan="2">regular rate &amp; rhythm, no murmurs</td></tr><tr><td>Chest:</td><td colspan="2">normal expansion</td></tr><tr><td>Lungs:</td><td colspan="2">+ diminished breath sounds   </td></tr><tr><td>Abdomen:</td><td colspan="2">soft, nondistended, nontender</td></tr><tr><td>Extremities:</td><td colspan="2">+ sen ecch</td></tr><tr><td>Musculoskeletal:</td><td colspan="2">+ antalgic gait</td></tr><tr><td>HEENT</td><td colspan="2">pupils equally reactive, no jaundice</td></tr><tr><td>Extremities</td><td colspan="2">no cyanosis, no edema, good distal pulses</td></tr></tbody></table><br/></li></ul></div><br/><br/></body></html>